Theravance Biopharma Inc
TBPH18.730USD
+0.160+0.86%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
949.09MMarket Cap
32.30P/E TTM
Theravance Biopharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
64.38M
12.12%
EPS(YoY)
-1.15
-15.73%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its total revenue reached 64.38M, with a year-on-year change of 12.12%.
What is the Earnings Per Share (EPS) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.155, with a year-on-year change of -15.73%.
What is the net income of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its net income was -56.42M, with a year-on-year change of -2.22%.
What is the net margin of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its net profit margin was -87.63%, with a year-on-year change of 8.83%.
What is the gross margin of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its debt-to-asset ratio was 8.57%, with a year-on-year change of 17.74%.
What is the Return on Equity (ROE) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -29.04%, with a year-on-year change of -72.27%.
What is the Return on Assets (ROA) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -15.33%, with a year-on-year change of -37.38%.
What is the operating profit of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its operating profit was -42.44M, with a year-on-year change of 20.37%.
What are the current assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its current assets were 161.07M, with a year-on-year change of 20.61%.
What are the total assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its total assets of Theravance Biopharma Inc were 354.16M, with a year-on-year change of -7.29%.
What are the total liabilities of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its total liabilities of Theravance Biopharma Inc were 178.62M, with a year-on-year change of 5.69%.
What is the total equity of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its total equity of Theravance Biopharma Inc was 175.54M, with a year-on-year change of -17.58%.
What is the net operating income of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its net operating income of Theravance Biopharma Inc was -56.42M, with a year-on-year change of -2.22%.
What is the net investment of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its net investment of Theravance Biopharma Inc was 12.28M, with a year-on-year change of 137.57%.
What is the net financing of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2024 earnings report, its net financing of Theravance Biopharma Inc was -2.50M, with a year-on-year change of 98.74%.
